• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Study on regulatory mechanism for cardiac contraction : seeking for therapeutic basis of heart failure.

Research Project

Project/Area Number 10307056
Research Category

Grant-in-Aid for Scientific Research (A).

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionUniversity of Tokyo

Principal Investigator

NAGAO Taku  Graduate School of Pharmaceutical Sciences, Laboratory of Pharmacology and Toxicology, University of Tokyo Professor, 大学院・薬学系研究科, 教授 (30217971)

Co-Investigator(Kenkyū-buntansha) ADACHI-AKAHANE Satomi  Graduate School of Pharmaceutical Sciences, Laboratory of Pharmacology and Toxicology, University of Tokyo Assistant professor, 大学院・薬学系研究科, 助手 (00184185)
KUROSE Hitoshi  Graduate School of Pharmaceutical Sciences, Laboratory of Pharmacology and Toxicology, University of Tokyo Associate Professor, 大学院・薬学系研究科, 助教授 (10183039)
Project Period (FY) 1998 – 2000
KeywordsHeart failure / Excitation-contraction coupling / Cardiac muscle / Ca^<2+> transients / L-type Ca^<2+> channel / Ca^<2+> handling / β adrenergic receptors / Myocardial infarction model
Research Abstract

The aim of this project was to open up a novel concept for therapeutic basis of heart failure. In the past three years from 1998 through 2000, we have carried out the research project by focusing on Ca^<2+> signaling in cardiac E-C coupling at the early stage of heart failure, molecular basis for cardiac protection against ischemia, molecular mechanism underlying modulation of L-type Ca^<2+> channel gating, cellular mechanism for desensitization of β adrenergic receptors. Our research products are summarized as follows :
1) With respect to the molecular basis for cardiac protection against ischemia, we found that ROS (reactive oxygen species) directly activates Gi and Go, which results in the activation of ERK (extracellular signal-regulated kinase). We opened up a novel concept that ROS is also involved in the signal transduction pathway leading to cardiac protection. 2) We identified Ser1115 in the pore domain of L-type Ca^<2+> channel α_<1C> subunit as the critical determinant for modulation of L-type Ca^<2+> channel gating by Ca^<2+> channel agonists by comparing the amino acid sequences between DHP-sensitive mammalian α_<1C> subunit and DHP-insensitive Ca^<2+> channel α_1 subunit of sea animals. Our finding opened up a novel concept in the gating mechanism of voltage-dependent Ca^<2+> channels. We also found that Ser1901 in the carboxy terminal of L-type Ca^<2+> channel α_<1C> subunit is the target for the PKA-modulation. 3) We found that, in the early adaptive stage of heart failure, the Ca^<2+> handling mechanism, especially Na^<+-> Ca^<2+> exchange activity, is up-regulated in ventricular myocytes of coronary artery ligation model rats. 4) We clarified the molecular basis for the tolerance of β_1 adrenergic receptors against internalization on exposure to β adrenergic agonists, which partially explains the reason for the slower rate of down regulation β_1 adrenergic receptors.

  • Research Products

    (40 results)

All Other

All Publications (40 results)

  • [Publications] Kikkawa,H. et al.: "The role of the seventh Transmembrane region in high-affinity binding of a β_2-selective agonist TA-2005."Mol.Pharmacol.. 53. 128-134 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hamada,K. et al.: "Shortening of monophasic action potential duration during hyperkalemia and myocardial ischemia in anesthetized dogs."Jpn.J.Pharmacol.,. 76. 149-154 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kanda,S. et al.: "Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca^<2+> channels."Eur.J.Pharmacol.. 358. 277-287 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Isogaya,M. et al: "Identification of a key amino acid of the β_2-adrenergic receptor for high affinity binding of salmeterol."Mol.Pharmacol.. 54. 576-579 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakamoto,K., et al: "Translocation of HSP27 to cytoskeleton by repetitive hypoxia-reoxygenation in the rat myoblast cell line, H9c2."Biochem.Biophys.Res.Comm.. 251. 576-579 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hamada,K., et al: "Shortening of action potential duration is not prerequisite for cardiac protection by ischemic preconditioning or a K_<ATP> channel opener."J.Mol.Cell.Cardiol.. 30. 1369-1379 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato,R., et al: "Temporal differences in actions of calcium channel blockers on K^+ accumulation cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts."J.Pharm.Exp.Ther.. 289. 831-839 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishida,M., et al: "Treatment with l-cis diltiazem before reperfusion reduces infarct size in the ischemic rabbit heart in vivo."Jpn.J.Pharmacol.. 80. 319-325 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishida,M., et al: "Activation of Rac 1 increases c-Jun NH2-terminal kinase activity and DNA fragmentation in a calcium-dependent manner in rat myoblast cell line H9c2."Biochem.Biophys.Res.Comm.. 262. 350-354 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Akiyama,C., et al: "Analysis of domain responsible for desensitization of β_1-adrenergic receptor."Jpn.J.Pharmacol.. 81. 12-20 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato,T., et al: "The contribution of third serine residue of β_2-adrenoceptor to interaction with and activation by isoproterenol."Br.J.Pharmacol.. 128. 272-274 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Isogaya,M., et al: "Binding pockets of the B^1-and β_2-adrenergic receptors for subtype selective agonists."Mol.Pharmacol.. 56. 875-885 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takesono,A., et al: "Negative regulation of α_2-adrenergic receptor-mediated G_i signaling by a novel pathway."Biochem.J.. 343. 77-85 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishida,M., et al: "l-cis Diltiazem attenuates intracellular Ca^<2+> overload by metabolic inhibition in guinea pig myocytes."Eur.J.Pharmacol.. 385. 225-230 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shiina,T., et al: "Interaction with β-arrestin determines the difference in internalization behavior between β_1-and β_2-adrenergic receptors."J.Biol.Chem.. 275. 29082-29090 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishida,M., et al: "G_<iα> and G_<oα> are target proteins of reactive oxygen species."Nature. 408. 492-495 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakamoto,K., et al: "Translocation of HSP27 to sarcomere induced by ischemic preconditioning in isolated rat hearts."Biochem.Biophys.Res.Comm.. 269. 137-142 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakamoto,K., et al: "Energy preserving effect of l-cis diltiazem in isolated ischemic and reperfused guinea pig hearts : A^<31>P-NMR study."Jpn.J.Pharmacol.. 83. 225-232 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaguchi,S. et al: "Serine residue in IIIS5-S6 linker of L-type Ca^<2+> channel α_<1C> subunit is the critical determinant of the action of dihydropyridine Ca^<2+> channel agonists."J.Biol.Chem.. 275. 41504-41511 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] I.Naguro,I., et al: "Ser^<1901> of α_<1C> subunit is required for the PKA-mediated enhancement of L-type Ca^<2+> channel currents but not for the negative shift of activaton."FEBS Letters. 489. 87-91 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kikkawa, H., Isogaya, M., Nagao, T., and Kurose, H.: "The role of the seventh Transmembrane region in high-affinity binding of a β_2-selective agonist TA-2005."Mol. Pharmacol.. 53. 128-134 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hamada, K., Yamazaki, J., and Nagao, T.: "Shortening of monophasic action potential duration during hyperkalemia and myocardial ischemia in anesthetized dogs."Jpn.J.Pharmacol.. 76. 149-154 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kanda, S., Adachi-Akahane, S., and Nagao, T.: "Functional interaction between benzothiazepine-and dihydropyridine binding sites of cardiac L-type Ca^<2+> channels."Eur.J.Pharmacol.. 358. 277-287 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Isogaya, M., Yamagiwa, Y., Fujita, S., Sugimoto, Y., T.Nagao, and H.Kurose: "Identification of a key amino acid of the β_2-adrenergic receptor for high affinity binding of salmeterol."Mol.Pharmacol.. 54. 616-622 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakamoto, K., Urushidani, T., and Nagao, T.: "Translocation of HSP27 to cytoskeleton by repetitive hypoxia-reoxygenation in the rat myoblast cell line, H9c2."Biochem.Biophys.Res.Comm.. 251. 576-579 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hamada, K., Yamazaki, J., and Nagao, T.: "Shortening of action potential duration is not prerequisite for cardiac protection by ischemic preconditioning or a K_<ATP> channel opener."J.Mol.Cell.Cardiol.. 30. 1369-1379 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato, R., Yamazaki, J., and Nagao, T.: "Temporal differences in actions of calcium channel blockers on K^+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts."J.Pharm.Exp.Ther.. 289. 831-839 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishida, M., Sakamoto, K., Urushidani, T., and Nagao, T.: "Treatment with 1-cis diltiazem before reperfusion reduces infarct size in the ischemic rabbit heart in vivo."Jpn.J.Pharmacol.. 80. 319-325 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishida, M., Nagao, T,, and Kurose, H.: "Activation of Rac 1 increases c-Jun NH2-terminal kinase activity and DNA fragmentation in a calcium-dependent manner in rat myoblast cell line H9c2."Biochem.Biophys.Res.Comm.. 262. 350-354 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akiyama, C., Nagao, T., and Kurose, H.: "Analysis of domain responsible for desensitization of β_1-adrenergic receptor."Jpn.J.Pharmacol.. 81. 12-20 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato, T., Nagao, T., and Kurose, H.: "The contribution of third serine residue of β_2-adrenoceptor to interaction with and activation by isoproterenol."Br.J.Pharmacol.. 128. 272-274 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Isogaya, M., Sugimoto, Y., Tanimura, R., Tanaka, R., Kikkawa, H., Nagao, T., and Kurose, H.: "Binding pockets of the β_1-and β_2-adrenergic receptors for subtype selective agonists."Mol.Pharmacol.. 56. 875-885 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takesono, A., Zahner, J., Blumer, K.J., Nagao, T., and Kurose, H.: "Negative regulation of α_2-adrenergic receptor-mediated G_i signaling by a novel pathway."Biochem.J.. 343. 77-85 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishida, M., Urushidani, T., Sakamoto, K., and Nagao, T.: "l-cis Diltiazem attenuates intracellular Ca^<2+> overload by metabolic inhibition in guinea pig myocytes."Eur.J.Pharmacol.. 385. 225-230 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shiina, T., Kawasaki, A., Nagao, T., and Kurose, H.: "Interaction with β-arrestin determines the difference in internalization behavior between β_1-and β_2-adrenergic receptors."J.Biol.Chem.. 275. 29082-29090 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishida, M., Maruyama, Y., Tanaka, R., Kontani, K., Nagao, T., and Kurose, H.: "G_<iα> and G_<oα> are target proteins of reactive oxygen species."Nature. 408. 492-495 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakamoto, K., Urushidani, T., and Nagao, T.: "Translocation of HSP27 to sarcomere induced by ischemic preconditioning in isolated rat hearts."Biochem.Biophys.Res.Comm.. 269. 137-142 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakamoto, K., Ishikawa, M., Koga, K., Urushidani, T., and Nagao, T.: "Energy preserving effect of l-cis diltiazem in isolated ischemic and reperfused guinea pig hearts : A^<31> P-NMR study."Jpn.J.Pharmacol.. 83. 225-232 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaguchi, S., Okamura, Y., Nagao, T., and Adachi-Akahane, S.: "Serine residue in IIIS5-S6 linker of L-type Ca^<2+> channel α_<1C> subunit is the critical determinant of the action of dihydropyridine Ca^<2+> channel agonists."J.Biol.Chem.. 275. 41504-41511 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Naguro, I., Nagao, T., and Adachi-Akahane, S.: "Ser^<1901> of α_<1C> subunit is required for the PKA-mediated enhancement of L-type Ca^<2+> channel currents but not for the negative shift of activaton."FEBS Letters. 489. 87-91 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi